Computed tomography (CT) scan evaluation of late toxicity following hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) in breast cancer patients treated with conservative surgery

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 29, Issue 5, 2006, Pages 479-483

  Manavis, John ^a   Ambatzoglou, John ^a   Sismanidou, Kyriaki ^a   Koukourakis, Michael I ^a,b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b DUTh ^*  (Greece)

Author keywords

Accelerated radiotherapy; Amifostine; Breast cancer; Hypofractionation; Late toxicity

Indexed keywords

AMIFOSTINE; ANTIESTROGEN; ANTIHISTAMINIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; METHYLPREDNISOLONE; STEROID; TAXANE DERIVATIVE; TROPISETRON;

ADULT; AGED; AGING; ARM DISEASE; ARTICLE; BREAST CANCER; BREAST CONSERVATION SURGERY; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CELL PROTECTION; CLINICAL ARTICLE; COHORT ANALYSIS; COLLIMATOR; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; ERYTHEMA; FATIGUE; FEMALE; FEVER; FOLLOW UP; HUMAN; HYPOFRACTIONATED ACCELERATED RADIOTHERAPY; HYPOTENSION; LINEAR ACCELERATOR; LUNG TOXICITY; MALE; NAUSEA; PALPATION; PATIENT SAFETY; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PROTECTION; RASH; VOMITING;

ADULT; AGED; AMIFOSTINE; ANTINEOPLASTIC AGENTS; BREAST; BREAST NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG; MIDDLE AGED; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33749540476     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000227482.36289.f2     Document Type: Article

References (16)

1. Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet. 1996;348:708-713.
2. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med. 1995;333:1444-1455.
3. Huston TL, Simmons RM. Locally recurrent breast cancer after conservation therapy. Am J Surg. 2005;189:229-235.
4. Pignol JP, Keller B, Rakovitch E, et al. First report of a permanent breast (103)Pd seed implant as adjuvant radiation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2006;64:176-181.
5. Arthur DW, Vicini FA. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol. 2005;23:1726-1735.
6. Whelan T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94:1143-1150.
7. Baillet F, Housset M, Maylin C, et al. The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients. Int J Radiat Oncol Biol Phys. 1990;19:1131-1133.
8. Ortholan C, Hannoun-Levi JM, et al. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. Int J Radiat Oncol Biol Phys. 2005;61:154-162.
9. Recht A. Is adjuvant hypofractionated radiotherapy appropriate for elderly patients with breast cancer? Nature Clin Pract Oncol. 2005;2:244-245.
10. Koukourakis MI, Giatromanolaki A, Kouroussis C, et al. Tumor and Angiogenesis Research Group. Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients. Int J Radiat Oncol Biol Phys. 2002;52:144-155.
11. Macejewski B, Taylor JM, Wither HR. Alpha/beta and the importance of the size of dose per fraction for late complications in the supraglottic larynx. Radiother Oncol. 1986;7:323-326.
12. Koukourakis MI, Damilakis J. LQ-based model for biological radiotherapy planning. Med Dosim. 1994;19:269-277.
13. Athas WF, Adams-Cameron M, Hunt WC, et al. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000;92:269-271.
14. Fletcher GH. Hypofractionation: lessons from complications. Radiother Oncol. 1991;20:10-15.
15. Yu TK, Whitman GJ, Thames HD, et al. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. J Natl Cancer Inst. 2004;96:1676-1681.
16. Choi NC. Radioprotective effect of amifostine in radiation pneumonitis. Semin Oncol. 2003;30(Suppl. 18):10-17.